Could a bone drug shrink cartilage tumors before surgery?
NCT ID NCT03173976
First seen Nov 06, 2025 · Last updated May 21, 2026 · Updated 27 times
Summary
This early-phase trial tests whether zoledronic acid, a drug used to strengthen bones, can help people with a rare cartilage cancer called chondrosarcoma. About 17 adults with tumors that can be removed by surgery will receive the drug before their operation. The main goals are to check for side effects and see if the drug reduces tumor activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHONDROSARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.